The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States

References

• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113(11):2386–2393. doi:10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106(7):2244–2251. doi:10.1182/blood-2004-12-4598
   PubMed Web of Science ®Google Scholar
• D’Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol 2013;35(1):1–13. doi:10.1097/MPH.0b013e318271f457
   PubMedGoogle Scholar
• Yenicesu I, Yetgin S, Ozyürek E, Aslan D. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol 2002;19(6):433–437. doi:10.1080/08880010290097233
   PubMed Web of Science ®Google Scholar
• O’Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 2012;129(2):248–255. doi:10.1542/peds.2011-1111
   PubMed Web of Science ®Google Scholar
• Hsieh YL, Lin LH. Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades. J Chin Med Assoc 2010;73(12):634–637. doi:10.1016/S1726-4901(10)70138-6
   PubMed Web of Science ®Google Scholar
• Kuhne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001;358(9299):2122–2125. doi:10.1016/S0140-6736(01)07219-1
   PubMed Web of Science ®Google Scholar
• Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematol Am Soc Hematol Educ Program 2006;97–103. doi:10.1182/asheducation-2006.1.97
   PubMedGoogle Scholar
• Cooper N. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia. Hematol Oncol Clin North Am 2009;23(6):1317–1327. doi:10.1016/j.hoc.2009.09.002
   PubMed Web of Science ®Google Scholar
• Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood 1986;67(1):203–206.
   PubMed Web of Science ®Google Scholar
• Newland AC, Treleaven JG, Minchinton RM, Waters AH. High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet 1983;1(8316):84–87. doi:10.1016/s0140-6736(83)91738-5
   PubMed Web of Science ®Google Scholar
• Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol 2010;85(3):174–180. doi:10.1002/ajh.21616
   PubMed Web of Science ®Google Scholar
• Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am 2013;27(3):495–520. doi:10.1016/j.hoc.2013.03.001
   PubMed Web of Science ®Google Scholar
• Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 2010;149(6):855–864. doi:10.1111/j.1365-2141.2010.08176.x
   PubMed Web of Science ®Google Scholar
• Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PHB, Bennett CM, Neufeld E, Vesely SK, Adix L, Blanchette VS, Kühne T. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the intercontinental cooperative ITP study group (ICIS). Blood 2013;121(22):4457–4462. doi:10.1182/blood-2012-12-466375
   PubMed Web of Science ®Google Scholar
• Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, et al. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. Am J Hematol 2018;93(7):882–888. doi:10.1002/ajh.25110
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115(2):168–186. doi:10.1182/blood-2009-06-225565
   PubMed Web of Science ®Google Scholar
• Donato H, Picón A, Martinez M, Rapetti MC, Rosso A, Gomez S, Rossi N, Bacciedoni V, Schvartzman G, Riccheri C, et al. Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina. Pediatr Blood Cancer 2009;52(4):491–496. doi:10.1002/pbc.21872
   PubMed Web of Science ®Google Scholar
• Heitink-Polle KM, Nijsten J, Boonacker CWB, de Haas M, Bruin MCA. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 2014;124(22):3295–3307. doi:10.1182/blood-2014-04-570127
   PubMed Web of Science ®Google Scholar
• Imbach P, Kühne T, Müller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006;46(3):351–356. doi:10.1002/pbc.20453
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117(16):4190–4207. doi:10.1182/blood-2010-08-302984
   PubMed Web of Science ®Google Scholar
• Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, Kelton JG, Arnold DM. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thrombosis Haemostasis 2015;13(3):457–464. doi:10.1111/jth.12813
   PubMed Web of Science ®Google Scholar
• Tarantino MD, Danese M, Klaassen RJ, Duryea J, Eisen M, Bussel J. Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets 2016;27(5):472–478. doi:10.3109/09537104.2016.1143923
   PubMed Web of Science ®Google Scholar
• Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol 2004;75(1):12–17. doi:10.1002/ajh.10445
   PubMed Web of Science ®Google Scholar
• Altomare I, Cetin K, Wetten S, Wasser JS. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol 2016;8:231–239. doi:10.2147/CLEP.S105888
   PubMed Web of Science ®Google Scholar